To identify Cushing’s Syndrome.
The Overnight Dexamethasone Suppression Test is used as an initial screening test.
We are pleased to advise that deep linking capability, enabling users to directly download individual mobile toolkits, has now been released on the RDS mobile app. When you install the update, you will see that each toolkit has a small QR code icon the header area beside the search icon – see screenshot below. Clicking on this icon will open up a window with a full-size QR code and the alternative of a short URL for sharing with users. Instructions are provided.
You may need to actively install the update to install RDS app version 4.7.1 to see this improvement. Installing this update is also strongly recommended to get the full benefits of the new contingency arrangements – specifically, that if the RDS website should fail, you will still be able to download new mobile app toolkits.
To check your current RDS version, click on the three dots bottom right of the RDS app screen. This takes you to a “More” page where you will see the version number. To install latest updates:
On iPhones – go to the Apple store, click on your profile icon top right, scroll down to see the apps waiting to be updated and update the RDS app.
On Android phones – these can vary, but try going to the Google Play store, click on your profile icon top right, click on “Manage apps and device”, select and update the RDS app.
Please get in touch with ann.wales3@nhs.scot with any questions.
The Overnight Dexamethasone Suppression Test is used as an initial screening test.
No specific preparation required.
Ensure the patient is not taking steroids in any form.
Dexamethasone 10 micrograms per kg body weight up to a maximum of 1 mg.
Available as scored 500 microgram tablets.
Round the dose to the dearest 250 micrograms (i.e. half a tablet).
Orally in tablet form.
Give the dose of dexamethasone between 23:00 and midnight.
Time (minutes) | Action |
23:00 to 00:00 | Give dexamethasone orally. |
09:00 next day | Take blood sample. |
Time | |
09:00 | Cortisol |
In normal subjects, the morning plasma cortisol concentration is suppressed to less than 50 nmol/l.
In patients with Cushing’s syndrome, such marked suppression is not observed.
Patients taking hepatic enzyme-inducing drugs (e.g. phenytoin, phenobarbitone) may have false negative results.